Evidence map›Paper›PMID 38155577›Full record

ArticleBiophysical journal2024

Unmasking subtype-dependent susceptibility to C-type inactivation in mammalian Kv1 channels.

Victoria A Baronas, Anson Wong, Damayantee Das, Shawn M Lamothe, Harley T Kurata

Open access · bronzeAbstract read
In one paragraph

Article in Biophysical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Victoria A BaronasDepartment of Pharmacology, Alberta Diabetes Institute, University of Alberta, Alberta, Edmonton, Canada.
Anson WongDepartment of Pharmacology, Alberta Diabetes Institute, University of Alberta, Alberta, Edmonton, Canada.
Damayantee DasDepartment of Pharmacology, Alberta Diabetes Institute, University of Alberta, Alberta, Edmonton, Canada.
Shawn M LamotheDepartment of Pharmacology, Alberta Diabetes Institute, University of Alberta, Alberta, Edmonton, Canada.
Harley T KurataDepartment of Pharmacology, Alberta Diabetes Institute, University of Alberta, Alberta, Edmonton, Canada. Electronic address: kurata@ualberta.ca.
University of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Shaker potassium channels have been an essential model for studying inactivation of ion channels and shaped our earliest understanding of N-type vs. C-type mechanisms. In early work describing C-type inactivation, López-Barneo and colleagues systematically characterized numerous mutations of Shaker residue T449, demonstrating that this position was a key determinant of C-type inactivation rate. In most of the closely related mammalian Kv1 channels, however, a persistent enigma has been that residue identity at this position has relatively modest effects on the rate of inactivation in response to long depolarizations. In this study, we report alternative ways to measure or elicit conformational changes in the outer pore associated with C-type inactivation. Using a strategically substituted cysteine in the outer pore, we demonstrate that mutation of Kv1.2 V381 (equivalent to Shaker T449) or W366 (Shaker W434) markedly increases susceptibility to modification by extracellularly applied MTSET. Moreover, due to the cooperative nature of C-type inactivation, Kv1.2 assembly in heteromeric channels markedly inhibits MTSET modification of this substituted cysteine in neighboring subunits. The identity of Kv1.2 residue V381 also markedly influences function in conditions that bias channels toward C-type inactivation, namely when Na

Indexed as

Ion Channel GatingKv1.2 Potassium ChannelAnimalsHumansMutationShaker Superfamily of Potassium ChannelsKv1.2 Potassium ChannelShaker Superfamily of Potassium Channels

Identifiers

PMID38155577
PMCPMC11309977
OpenAlexW4390350173

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.